Robert H. Diamond

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

Jean‐Frédéric Colombel, William J. Sandborn, Walter Reinisch et al. · New England Journal of Medicine · 2010 · 3.1K citations · Full text

Pharmacy, Immunology, Pharmacotherapy +14

Serious Infections and Mortality in Association With Therapies for Crohn’s Disease: TREAT Registry

Gary R. Lichtenstein, Brian G. Feagan, Russell D. Cohen et al. · Clinical Gastroenterology and Hepatology · 2006 · 907 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +13

Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ Registry

Gary R. Lichtenstein, Brian G. Feagan, Russell D. Cohen et al. · The American Journal of Gastroenterology · 2012 · 796 citations

Medicine, Clinical Sciences, Pharmacotherapy +13

Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn’s disease

Stephen B. Hanauer, Carrie Wagner, Mohan Bala et al. · Clinical Gastroenterology and Hepatology · 2004 · 608 citations · Full text

Veterinary Medicine, Immunology, Pharmacotherapy +16

Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease

Paul Rutgeerts, Robert H. Diamond, Mohan Bala et al. · Gastrointestinal Endoscopy · 2006 · 549 citations

Pharmacy, Pharmacotherapy, Gastrointestinal Pharmacotherapy +13